Camrelizumab Combined With Apatinib in the Treatment of Patients With Advanced Gastric Cancer and Colorectal Cancer

Summary

The efficacy and safety of the use of Camrelizumab combined with Apatinib

Timeline

Start

2019-08-20

Primary completion

2020-09-23

Completion

2021-10-31

Publications

• Zhao L, Gao C, Qiao X, Lou F, Zheng B, Fu M, Huang X, Xie X, Zhang W, Hong Y, Rong K, Shi H, Xiao L, Hu T. Apatinib enhances anti-PD-1 efficacy by inhibiting Exo70-mediated exosome secretion in pMMR/MSS colorectal cancer. NPJ Precis Oncol. 2026 May 30. doi: 10.1038/s41698-026-01518-7. Online ahead of print.

Drugs

Indications